Table 5

Widest study results against Benestent II results

PTCAStent
WidestBenestent IIWidestBenestent II
Crossover30.1%13.4%1.9%3.4%
FU angiogram83%51%90%50.1%
Restenosis rate17.3%31%21.6%16%
Early events6.8%5.1%7.8%3.9%
One year events19.2%23.4%5-150 20.8%20.7%5-150
  • 5-150 In angiogram follow up patients.

  • FU, follow up.